These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17703232)

  • 1. Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L.
    Berg D; Lehne M; Müller N; Siegmund D; Münkel S; Sebald W; Pfizenmaier K; Wajant H
    Cell Death Differ; 2007 Dec; 14(12):2021-34. PubMed ID: 17703232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.
    Wyzgol A; Müller N; Fick A; Munkel S; Grigoleit GU; Pfizenmaier K; Wajant H
    J Immunol; 2009 Aug; 183(3):1851-61. PubMed ID: 19596991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of soluble TRAIL and membrane TRAIL in Jurkat cells by PMA].
    Li Y; Cao YX; Zhang Y; Song CJ; Zhuang R; Fang L; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):276-9. PubMed ID: 15862138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimeric coiled-coil domain of human pulmonary surfactant protein D enhances zinc-binding ability and biologic activity of soluble TRAIL.
    Wu X; Li P; Qian C; Li O; Zhou Y
    Mol Immunol; 2009 Jul; 46(11-12):2381-8. PubMed ID: 19481806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior serum half life of albumin tagged TNF ligands.
    Müller N; Schneider B; Pfizenmaier K; Wajant H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):793-9. PubMed ID: 20447380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death ligands designed to kill: development and application of targeted cancer therapeutics based on proapoptotic TNF family ligands.
    Gerspach J; Wajant H; Pfizenmaier K
    Results Probl Cell Differ; 2009; 49():241-73. PubMed ID: 19142623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95.
    Assohou-Luty C; Gerspach J; Siegmund D; Müller N; Huard B; Tiegs G; Pfizenmaier K; Wajant H
    J Mol Med (Berl); 2006 Sep; 84(9):785-97. PubMed ID: 16924474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.
    Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP
    Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
    Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
    J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand.
    Duus K; Pagh RT; Holmskov U; Højrup P; Skov S; Houen G
    Scand J Immunol; 2007 Nov; 66(5):501-7. PubMed ID: 17953526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering death receptor ligands for cancer therapy.
    Wajant H; Gerspach J; Pfizenmaier K
    Cancer Lett; 2013 May; 332(2):163-74. PubMed ID: 21236560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N; Matsuda-Minehata F; Goto Y; Maeda A; Cheng Y; Nakagawa S; Inoue N; Wongpanit K; Jin H; Gonda H; Li J
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():268-72. PubMed ID: 18638134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization.
    Müller N; Wyzgol A; Münkel S; Pfizenmaier K; Wajant H
    FEBS J; 2008 May; 275(9):2296-304. PubMed ID: 18397322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
    Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
    J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
    McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
    J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells and eosinophils in bronchial smooth muscle cell death in asthma.
    Solarewicz-Madejek K; Basinski TM; Crameri R; Akdis M; Akkaya A; Blaser K; Rabe KF; Akdis CA; Jutel M
    Clin Exp Allergy; 2009 Jun; 39(6):845-55. PubMed ID: 19400895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.